GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: selection of NN2211 for clinical development. - Knudsen,L.B.; Agerso,H.; Bjenning,C.; Bregenholt,S.; Carr,R.D.; Godtfredsen,C.; Holst,J.J.; Huusfeldt,P.O.; Larsen,M.O.; Larsen,P.J.; Nielsen,P.F.; Ribel,U.; et al. (Drugs Future, 2001)